Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-06-27

Clinical Trial Update: Study of Fecal Microbiota Transplantation (FMT) in Severe IBS Patients [Phase 3]

View source ↗

Summary

Phase 3 study evaluating fecal microbiota transplantation for severe irritable bowel syndrome is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Irritable Bowel Syndrome | Phase 3 | Status: NOT_YET_RECRUITING